Literature DB >> 21299445

Update on stem cell therapy for cerebral palsy.

James E Carroll1, Robert W Mays.   

Abstract

INTRODUCTION: Due to the publicity about stem cell transplantation for the treatment of cerebral palsy, many families seek information on treatment, and many travel overseas for cell transplantation. Even so, there is little scientific confirmation of benefit, and therefore existing knowledge in the field must be summarized. AREAS COVERED: This paper addresses the clinical protocols examining the problem, types of stem cells available for transplant, experimental models used to test the benefit of the cells, possible mechanisms of action, potential complications of cell treatment and what is needed in the field to help accelerate cell-based therapies. EXPERT OPINION: While stem cells may be beneficial in acute injuries of the CNS the biology of stem cells is not well enough understood in chronic injuries or disorders such as cerebral palsy. More work is required at the basic level of stem cell biology, in the development of animal models, and finally in well-conceived clinical trials.

Entities:  

Mesh:

Year:  2011        PMID: 21299445      PMCID: PMC3057381          DOI: 10.1517/14712598.2011.557060

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  57 in total

1.  Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors:  Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

2.  The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.

Authors:  A Peled; O Kollet; T Ponomaryov; I Petit; S Franitza; V Grabovsky; M M Slav; A Nagler; O Lider; R Alon; D Zipori; T Lapidot
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

3.  Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization.

Authors:  Jun-ichi Yamaguchi; Kengo Fukushima Kusano; Osamu Masuo; Atsuhiko Kawamoto; Marcy Silver; Satoshi Murasawa; Marta Bosch-Marce; Haruchika Masuda; Douglas W Losordo; Jeffrey M Isner; Takayuki Asahara
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats.

Authors:  J Chen; P R Sanberg; Y Li; L Wang; M Lu; A E Willing; J Sanchez-Ramos; M Chopp
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

5.  Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats.

Authors:  Li-Ru Zhao; Wei-Ming Duan; Morayma Reyes; C Dirk Keene; Catherine M Verfaillie; Walter C Low
Journal:  Exp Neurol       Date:  2002-03       Impact factor: 5.330

6.  Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury.

Authors:  Peter Riess; Chen Zhang; Kathryn E Saatman; Helmut L Laurer; Luca G Longhi; Ramesh Raghupathi; Philipp M Lenzlinger; Jonathan Lifshitz; John Boockvar; Edmund Neugebauer; Evan Y Snyder; Tracy K McIntosh
Journal:  Neurosurgery       Date:  2002-10       Impact factor: 4.654

7.  Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain.

Authors:  Yuehua Jiang; Ben Vaessen; Todd Lenvik; Mark Blackstad; Morayma Reyes; Catherine M Verfaillie
Journal:  Exp Hematol       Date:  2002-08       Impact factor: 3.084

Review 8.  Stem cell therapy for cerebral palsy.

Authors:  John Bartley; James E Carroll
Journal:  Expert Opin Biol Ther       Date:  2003-07       Impact factor: 4.388

9.  Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury.

Authors:  Dunyue Lu; Paul R Sanberg; Asim Mahmood; Yi Li; Lei Wang; Juan Sanchez-Ramos; Michael Chopp
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

10.  Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children.

Authors:  K W Chik; P K S Chan; C K Li; M M K Shing; V Lee; A F Cheng; P M P Yuen
Journal:  Bone Marrow Transplant       Date:  2002-06       Impact factor: 5.483

View more
  24 in total

Review 1.  Concise Review: Stem Cell Interventions for People With Cerebral Palsy: Systematic Review With Meta-Analysis.

Authors:  Iona Novak; Karen Walker; Rod W Hunt; Euan M Wallace; Michael Fahey; Nadia Badawi
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

Review 2.  Stem cells and cell-based therapies for cerebral palsy: a call for rigor.

Authors:  Lauren L Jantzie; Joseph Scafidi; Shenandoah Robinson
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

Review 3.  Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges.

Authors:  Yingchen Li; Guoheng Hu; Qilai Cheng
Journal:  Front Med       Date:  2014-12-09       Impact factor: 4.592

Review 4.  The Role of Stem Cells in the Treatment of Cerebral Palsy: a Review.

Authors:  Anahita Kiasatdolatabadi; Nasrin Lotfibakhshaiesh; Meysam Yazdankhah; Somayeh Ebrahimi-Barough; Mina Jafarabadi; Arman Ai; Esmaeil Sadroddiny; Jafar Ai
Journal:  Mol Neurobiol       Date:  2016-08-13       Impact factor: 5.590

5.  Using miRNA-mRNA Interaction Analysis to Link Biologically Relevant miRNAs to Stem Cell Identity Testing for Next-Generation Culturing Development.

Authors:  Marian A E Crabbé; Kristel Gijbels; Aline Visser; David Craeye; Sara Walbers; Jef Pinxteren; Robert J Deans; Wim Annaert; Bart L T Vaes
Journal:  Stem Cells Transl Med       Date:  2016-04-13       Impact factor: 6.940

6.  Updates in the treatment of spasticity associated with cerebral palsy.

Authors:  Ruba Benini; Michael I Shevell
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

Review 7.  Progress in clinical trials of stem cell therapy for cerebral palsy.

Authors:  Zhong-Yue Lv; Ying Li; Jing Liu
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

8.  Positron emission tomography-computer tomography scan used as a monitoring tool following cellular therapy in cerebral palsy and mental retardation-a case report.

Authors:  Alok Sharma; Hemangi Sane; Amruta Paranjape; Nandini Gokulchandran; Pooja Kulkarni; Anjana Nagrajan; Prerna Badhe
Journal:  Case Rep Neurol Med       Date:  2013-02-03

Review 9.  Human cord blood for the hypoxic-ischemic neonate.

Authors:  James Carroll
Journal:  Pediatr Res       Date:  2012-01-25       Impact factor: 3.756

10.  Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy.

Authors:  Guojun Chen; Yali Wang; Zhenyu Xu; Feng Fang; Renmei Xu; Yue Wang; Xiaoli Hu; Lixing Fan; Houqi Liu
Journal:  J Transl Med       Date:  2013-01-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.